TriMas Corporation (TRS) Earnings
TriMas Corporation is expected to report next earnings on July 28, 2026 (in NaN days), with a consensus EPS estimate of $0.49. TRS has beaten EPS estimates in 6 of its last 12 reported quarters (average surprise +11.6% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Apr 30, 2026 | $0.19 | $0.24 | +26.6% | $168M | +6.3% |
| Oct 28, 2025 | $0.56 | $0.61 | +8.2% | $269M | +2.7% |
| Jul 29, 2025 | $0.50 | $0.61 | +22.0% | $275M | +4.8% |
| Feb 27, 2025 | $0.48 | $0.43 | -10.4% | $228M | -4.5% |
| Apr 30, 2024 | $0.28 | $0.37 | +32.1% | $227M | +2.9% |
| Feb 29, 2024 | $0.54 | $0.37 | -31.5% | $210M | -15.0% |
| Oct 26, 2023 | $0.56 | $0.57 | +1.8% | $235M | -4.8% |
| Jul 27, 2023 | $0.50 | $0.50 | +0.0% | $233M | -8.8% |
| Apr 27, 2023 | $0.27 | $0.30 | +11.1% | $215M | +3.3% |
| Feb 23, 2023 | $0.66 | $0.62 | -6.1% | $203M | -3.9% |
| Oct 27, 2022 | $0.61 | $0.40 | -34.4% | $219M | -11.4% |
| Jul 28, 2022 | $0.60 | $0.60 | +0.0% | $238M | -0.5% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q1 FY2026 · April 30, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
• Successfully closed divestiture of TriMass Aerospace on March 16th, generating over $1.2 billion of net after-tax proceeds and strengthening balance sheet. • Repurchased nearly 1.5 million shares in first quarter, total since aerospace divestiture announcement ~4.5 million shares. • Priorities: investing in organic growth, strengthening core capabilities, pursuing targeted acquisitions in packaging and life sciences. • Intensified focus on operational improvements, including plans to consolidate Atkins, Arkansas packaging facility to generate additional savings. • Monitoring geopolitical developments and managing potential impacts on operations and supply chains.
Guidance
• Reaffirm full year 2026 sales growth of 3% to 6% based on $645.7 million revenue base. • Anticipate more than 300 basis points of operating profit margin improvement. • Full year 2026 adjusted diluted earnings per share guidance in range of $1.50 to $1.70. • Outlook assumes ~$9 million of interest income per remaining quarter, interest expense $20 - $22 million, reduction in corporate cash expense ~$10 million year-over-year, effective tax rate 27 - 29%. • Expect improvement in sales, earnings, and adjusted earnings per share each quarter of 2026 compared to prior year, sequential increases in earnings in Q2 and Q3.
Segment performance
Packaging segment: First quarter net sales increased 9.1% year over year to $139.2 million. Operating profit was $17.7 million. Specialty product segment: Net sales increased 17% to $29.1 million compared to $24.9 million a year ago. Operating profit improved from $100,000 in Q1 of 2025 to $2.9 million, with operating profit margin increasing to 9.8%.
Risks & headwinds
• Geopolitical developments, including conditions in the Middle East, and potential impacts on operations and supply chains.
Analyst Q&A
Q: Can you talk about price cost expectations within packaging and remind us what the typical lag versus commodity prices is before it flows through to the P&L?
A: There's a bit of lag on resin cost pass-through. Majority of business under contract with cost recovery language. Varied term timings. Anticipate not a lot of impact overall, but possible headwind in quarter with delay moving from Q2 to Q3. From full year perspective, feel good about price over cost recovery.
Q: How should we think about the cadence of improvement within packaging segment through the year?
A: Expected Q1 to be lowest from margin perspective, expected to increase sequentially. Other actions taken sufficient to see escalation into next two quarters, Q4 naturally falls back a bit but in line with full year guidance.
Q: Give more detail on MIPS impacts from tooling revenue within life sciences and if we should see that in coming quarters?
A: Had a tooling sale for a program with low margin, not inherent in Q1 guidance, pressured margins in Q1. No significant tooling sale forecasted for remainder of year, but it's a leading indicator of future sales improvements.